SAN FRANCISCO & GALWAY, Ireland--(BUSINESS WIRE)--Dance Pharma and Aerogen Ltd. will develop Dance’s inhaled insulin product in a novel aerosol device based on Aerogen’s proprietary OnQ™ Aerosol ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results